Association Between Second-Trimester Dyslipidemia And The Risk Of Developing Preeclampsia Among Pregnant Women With Subclinical Hypothyroidism
Adolescência e Saúde · 17.08.2026 · 21 (6s) · 106-113
DOI: 10.67440/ahj.v21i6s.1553 ↗Kurz gefasst
Fachartikel in der Zeitschrift Adolescência e Saúde, online erschienen am 17.08.2026. Verfasst von Duaa Khalid Ismail und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Subclinical hypothyroidism (SCH) is one of the most common endocrine disorders encountered during pregnancy and has been increasingly recognized as a contributor to adverse maternal and fetal outcomes.
Aim
This study aimed to evaluate the association between second-trimester dyslipidemia and the risk of developing preeclampsia among pregnant women with subclinical hypothyroidism and to identify clinically useful biochemical markers for early prediction of preeclampsia. Patients and Methods: A hospital-based case–control study was conducted at the Department of Obstetrics and Gynecology, Tikrit Teaching Hospital, Salah Al-Din Governorate, Iraq, from 1 October 2025 to 30 June 2026. A total of 120 pregnant women diagnosed with SCH during the second trimester were enrolled. The participants were divided into two equal groups: 60 women who subsequently developed preeclampsia (cases) and 60 women who remained normotensive throughout pregnancy (controls). fasting serum samples were analyzed for thyroid-stimulating hormone (TSH), free thyroxine (FT4), total cholesterol (TC), triglycerides (TG), low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C).
Results
Women who developed preeclampsia had significantly higher serum TSH concentrations than controls (5.92 ± 1.31 vs. 4.51 ± 0.88 mIU/L, P < 0.001), whereas FT4 levels did not differ significantly (P = 0.148). Maternal lipid profile demonstrated significantly higher concentrations of TC (228.64 ± 29.81 vs. 198.73 ± 24.16 mg/dL), TG (242.51 ± 47.36 vs. 182.45 ± 36.28 mg/dL), and LDL-C (146.82 ± 26.14 vs. 118.41 ± 22.33 mg/dL), together with significantly lower HDL-C levels (41.62 ± 6.83 vs. 50.48 ± 7.22 mg/dL) among women with preeclampsia (all P < 0.001). Composite dyslipidemia was present in 81.67% of cases compared with 45.00% of controls (P < 0.001). Serum TSH demonstrated significant positive correlations with TC (r = 0.421), TG (r = 0.487), and LDL-C (r = 0.394), while HDL-C showed a significant inverse correlation (r = −0.336).
Conclusions
Pregnant women with subclinical hypothyroidism who subsequently developed preeclampsia exhibited significantly more pronounced dyslipidemia and higher serum TSH concentrations than those who remained normotensive. Elevated triglycerides, total cholesterol, LDL-C, increased TSH, reduced HDL-C, and higher maternal BMI independently predicted the development of preeclampsia.
Zitieren
APA
Ismail, D. K., & Hassein, A. P. D. M. R. (2026). Association Between Second-Trimester Dyslipidemia And The Risk Of Developing Preeclampsia Among Pregnant Women With Subclinical Hypothyroidism. Adolescência e Saúde, 21(6s), 106-113. https://doi.org/10.67440/ahj.v21i6s.1553
Vancouver
Ismail DK, Hassein APDMR. Association Between Second-Trimester Dyslipidemia And The Risk Of Developing Preeclampsia Among Pregnant Women With Subclinical Hypothyroidism. Adolescência e Saúde. 2026;21(6s):106-113. doi:10.67440/ahj.v21i6s.1553
BibTeX
@article{Ismail2026,
author = {Ismail, Duaa Khalid and Hassein, Assist. Prof. Dr. Masryia Rashad},
title = {Association Between Second-Trimester Dyslipidemia And The Risk Of Developing Preeclampsia Among Pregnant Women With Subclinical Hypothyroidism},
journal = {Adolescência e Saúde},
year = {2026},
volume = {21},
number = {6s},
pages = {106--113},
doi = {10.67440/ahj.v21i6s.1553}
}
EUVIMED